Deerfield, IL, United States of America

Stephen L Axel

This inventor holds 1 USPTO granted patent. Top assignee: Baxter International Inc.. Active years: 2001.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 89(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Stephen L Axel

Introduction

Stephen L Axel is a notable inventor based in Deerfield, IL (US). He has made significant contributions to the field of medical technology, particularly in the area of medication management. His work focuses on improving patient care and enhancing the quality of life for individuals dealing with pain.

Latest Patents

Stephen L Axel holds a patent for a "Method and apparatus for automatically controlling the level of medication." This innovative method captures relevant information pertaining to a patient's physiological conditions. It automatically adjusts the amount of medication to optimize the treatment of pain and improve the patient's quality of life.

Career Highlights

Stephen is associated with Baxter International Inc., a leading company in the healthcare sector. His role at Baxter allows him to apply his inventive skills to develop solutions that address critical healthcare challenges. With a focus on patient-centered care, he continues to contribute to advancements in medical technology.

Collaborations

Stephen has collaborated with talented individuals such as Tuan Bui and Doron Levitas. These partnerships have fostered an environment of innovation and creativity, leading to the development of impactful medical solutions.

Conclusion

Stephen L Axel's contributions to the field of medical technology exemplify the importance of innovation in improving patient care. His patented method for medication management is a testament to his dedication to enhancing the quality of life for patients.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…